Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Diagnostic Pathology
Published in: Diagnostic Pathology 1/2014

Open Access 01-12-2014 | Research

Whole DNA methylome profiling in lung cancer cells before and after epithelial-to-mesenchymal transition

Authors: Fatao Liu, Yi Zhou, Daizhan Zhou, Mengyuan Kan, Xiaomin Niu, Zhou Zhang, Di Zhang, Liming Tao, Lin He, Lixing Zhan, Yun Liu

Published in: Diagnostic Pathology | Issue 1/2014

Login to get access

Abstract

Background

Metastatic lung cancer is one of the leading causes of cancer death. In recent years, epithelial-to-mesenchymal transition (EMT) has been found to contribute to metastasis, as it enables migratory and invasive properties in cancer cells. Previous genome-wide studies found that DNA methylation was unchanged during EMT induced by TGF-β in AML12 cells. In this study, we aimed to discover EMT-related changes in DNA methylation in cancer cells, which are poorly understood.

Methods

We employed a next-generation sequencing-based method, MSCC (methyl-sensitive cut counting), to investigate DNA methylation during EMT in the A549 lung cancer cell line.

Results

We found that methylation levels were highly correlated to gene expression, histone modifications and small RNA expression. However, no differentially methylated regions (DMRs) were found in A549 cells treated with TGF-β for 4 h, 12 h, 24 h and 96 h. Additionally, CpG islands (CGIs) showed no overall change in methylation levels, and at the single-base level, almost all of the CpGs showed conservation of DNA methylation levels. Furthermore, we found that the expression of DNA methyltransferase 1, 3a, 3b (DNMT1, DNMT3a, DNMT3b) and ten-eleven translocation 1 (TET1) was altered after EMT. The level of several histone methylations was also changed.

Conclusions

DNA methylation-related enzymes and histone methylation might have a role in TGF-β-induced EMT without affecting the whole DNA methylome in cancer cells. Our data provide new insights into the global methylation signature of lung cancer cells and the role of DNA methylation in EMT.

Virtual slides

The virtual slides for this article can be found here: http://​www.​diagnosticpathol​ogy.​diagnomx.​eu/​vs/​1112892497119603​
Appendix
Available only for authorised users
Literature
1.
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer J Int Du Cancer. 2010, 127 (12): 2893-2917.CrossRef
2.
Zheng S, Du Y, Chu H, Chen X, Li P, Wang Y, Ma Y, Wang H, Zang W, Zhang G, Zhao G: Analysis of MAT3 gene expression in NSCLC. Diagn Pathol. 2013, 8: 166-PubMedPubMedCentralCrossRef
3.
Lu Q, Lu S, Huang L, Wang T, Wan Y, Zhou CX, Zhang C, Zhang Z, Li X: The expression of V-ATPase is associated with drug resistance and pathology of non-small-cell lung cancer. Diagn Pathol. 2013, 8: 145-PubMedPubMedCentralCrossRef
4.
Xiong Y, Bai Y, Leong N, Laughlin TS, Rothberg PG, Xu H, Nong L, Zhao J, Dong Y, Li T: Immunohistochemical detection of mutations in the epidermal growth factor receptor gene in lung adenocarcinomas using mutation-specific antibodies. Diagn Pathol. 2013, 8 (1): 27-PubMedPubMedCentralCrossRef
5.
Saintigny P, Burger JA: Recent advances in non-small cell lung cancer biology and clinical management. Discov Med. 2012, 13 (71): 287-297.PubMed
6.
Thiery JP, Acloque H, Huang RY, Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell. 2009, 139 (5): 871-890.PubMedCrossRef
7.
Li J, Wang Y, Luo J, Fu Z, Ying J, Yu Y, Yu W: miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells. FEBS Lett. 2012, 586: 3761-3765.PubMedCrossRef
8.
Wu ZQ, Li XY, Hu CY, Ford M, Kleer CG, Weiss SJ: Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic breast cancer 1, early onset (BRCA1) repression. Proc Natl Acad Sci USA. 2012, 109: 16654-16659.PubMedPubMedCentralCrossRef
9.
Sethi S, Macoska J, Chen W, Sarkar FH: Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis. Am J Transl Res. 2010, 3 (1): 90-99.PubMedPubMedCentral
10.
11.
Jones PA: Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet. 2012, 13 (7): 484-492.PubMedCrossRef
12.
Suzuki MM, Bird A: DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet. 2008, 9 (6): 465-476.PubMedCrossRef
13.
14.
15.
16.
Cedar H, Bergman Y: Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet. 2009, 10 (5): 295-304.PubMedCrossRef
17.
Ito S, D’Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y: Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature. 2010, 466 (7310): 1129-1133.PubMedPubMedCentralCrossRef
18.
Lombaerts M, van Wezel T, Philippo K, Dierssen JW, Zimmerman RM, Oosting J, van Eijk R, Eilers PH, van de Water B, Cornelisse CJ, Cleton-Jansen AM: E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br J Cancer. 2006, 94 (5): 661-671.PubMedPubMedCentral
19.
Ke XS, Qu Y, Cheng Y, Li WC, Rotter V, Oyan AM, Kalland KH: Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells. BMC Genomic. 2010, 11: 669-CrossRef
20.
McDonald OG, Wu H, Timp W, Doi A, Feinberg AP: Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition. Nat Struct Mol Biol. 2011, 18 (8): 867-874.PubMedPubMedCentralCrossRef
21.
Guo JU, Ma DK, Mo H, Ball MP, Jang MH, Bonaguidi MA, Balazer JA, Eaves HL, Xie B, Ford E, Zhang K, Ming GL, Gao Y, Song H: Neuronal activity modifies the DNA methylation landscape in the adult brain. Nat Neurosci. 2011, 14 (10): 1345-1351.PubMedPubMedCentralCrossRef
22.
23.
Katakura Y, Nakata E, Miura T, Shirahata S: Transforming growth factor beta triggers two independent-senescence programs in cancer cells. Biochem Biophys Res Commun. 1999, 255 (1): 110-115.PubMedCrossRef
24.
Liu J, Hu G, Chen D, Gong AY, Soori GS, Dobleman TJ, Chen XM: Suppression of SCARA5 by Snail1 is essential for EMT-associated cell migration of A549 cells. Oncog. 2013, 2: e73-CrossRef
25.
Kitamura K, Seike M, Okano T, Matsuda K, Miyanaga A, Mizutani H, Noro R, Minegishi Y, Kubota K, Gemma A: MiR-134/487b/655 cluster regulates TGF-beta-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells. Mol Cancer Ther. 2014, 13 (2): 444-453.PubMedCrossRef
26.
27.
Siegel PM, Massague J: Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer. 2003, 3 (11): 807-821.PubMedCrossRef
28.
Moustakas A, Heldin P: TGFbeta and matrix-regulated epithelial to mesenchymal transition. Biochim Biophys Acta. 2014, in press
29.
30.
Ooi SK, Qiu C, Bernstein E, Li K, Jia D, Yang Z, Erdjument-Bromage H, Tempst P, Lin SP, Allis CD, Cheng X, Bestor TH: DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature. 2007, 448 (7154): 714-717.PubMedPubMedCentralCrossRef
31.
Brandeis M, Frank D, Keshet I, Siegfried Z, Mendelsohn M, Nemes A, Temper V, Razin A, Cedar H: Sp1 elements protect a CpG island from de novo methylation. Nature. 1994, 371 (6496): 435-438.PubMedCrossRef
32.
Siegfried Z, Eden S, Mendelsohn M, Feng X, Tsuberi BZ, Cedar H: DNA methylation represses transcription in vivo. Nature Genet. 1999, 22 (2): 203-206.PubMedCrossRef
33.
Frank D, Keshet I, Shani M, Levine A, Razin A, Cedar H: Demethylation of CpG islands in embryonic cells. Nature. 1991, 351 (6323): 239-241.PubMedCrossRef
34.
Hitchins MP, Rapkins RW, Kwok CT, Srivastava S, Wong JJ, Khachigian LM, Polly P, Goldblatt J, Ward RL: Dominantly inherited constitutional epigenetic silencing of MLH1 in a cancer-affected family is linked to a single nucleotide variant within the 5′UTR. Cancer cell. 2011, 20 (2): 200-213.PubMedCrossRef
35.
Hahn MA, Wu X, Li AX, Hahn T, Pfeifer GP: Relationship between gene body DNA methylation and intragenic H3K9me3 and H3K36me3 chromatin marks. PloS One. 2011, 6 (4): e18844-PubMedPubMedCentralCrossRef
36.
Eden S, Hashimshony T, Keshet I, Cedar H, Thorne AW: DNA methylation models histone acetylation. Nature. 1998, 394 (6696): 842-PubMedCrossRef
37.
Hashimshony T, Zhang J, Keshet I, Bustin M, Cedar H: The role of DNA methylation in setting up chromatin structure during development. Nature Genet. 2003, 34 (2): 187-192.PubMedCrossRef
38.
Zilberman D, Coleman-Derr D, Ballinger T, Henikoff S: Histone H2A.Z and DNA methylation are mutually antagonistic chromatin marks. Nature. 2008, 456 (7218): 125-129.PubMedPubMedCentralCrossRef
39.
Taberlay PC, Kelly TK, Liu CC, You JS, De Carvalho DD, Miranda TB, Zhou XJ, Liang G, Jones PA: Polycomb-repressed genes have permissive enhancers that initiate reprogramming. Cell. 2011, 147 (6): 1283-1294.PubMedPubMedCentralCrossRef
40.
Nguyen CT, Gonzales FA, Jones PA: Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation. Nucleic Acids Res. 2001, 29 (22): 4598-4606.PubMedPubMedCentralCrossRef
41.
42.
Rudenko A, Tsai LH: Epigenetic modifications in the nervous system and their impact upon cognitive impairments. Neuropharmacology. 2014, in press
43.
Tempera I, Lieberman PM: Epigenetic regulation of EBV persistence and oncogenesis. Semin Cancer Biol. 2014, in press
44.
Ghavifekr Fakhr M, Farshdousti Hagh M, Shanehbandi D, Baradaran B: DNA methylation pattern as important epigenetic criterion in cancer. Genet Res Int. 2013, 2013: 317569-PubMedPubMedCentral
45.
Tokarz P, Blasiak J: Role of DNA methylation in colorectal cancer. Postepy Biochem. 2013, 59 (3): 267-279.PubMed
46.
Sartor MA, Mahavisno V, Keshamouni VG, Cavalcoli J, Wright Z, Karnovsky A, Kuick R, Jagadish HV, Mirel B, Weymouth T, Athey B, Omenn GS: ConceptGen: a gene set enrichment and gene set relation mapping tool. Bioinformatics. 2010, 26 (4): 456-463.PubMedPubMedCentralCrossRef
Metadata
Title
Whole DNA methylome profiling in lung cancer cells before and after epithelial-to-mesenchymal transition
Authors
Fatao Liu
Yi Zhou
Daizhan Zhou
Mengyuan Kan
Xiaomin Niu
Zhou Zhang
Di Zhang
Liming Tao
Lin He
Lixing Zhan
Yun Liu
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2014
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/1746-1596-9-66

Other articles of this Issue 1/2014

Diagnostic Pathology 1/2014 Go to the issue

Research

Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature

Short report

An immunohistochemical study of canine spontaneous gastric polyps

Research

Epithelioid Hemangioendothelioma: clinicopathologic, immunhistochemical, and molecular genetic analysis of 39 cases

Research

Lack of association between a functional polymorphism (rs1800796) in the interleukin-6 gene promoter and lung cancer

Case Report

Case report: intraductal tubulopapillary neoplasm of the pancreas with unique clear cell phenotype

Research

The expression and clinical significance of miR-132 in gastric cancer patients